Literature DB >> 21658472

Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model.

Francesca Re1, Ilaria Cambianica, Cristiano Zona, Silvia Sesana, Maria Gregori, Roberta Rigolio, Barbara La Ferla, Francesco Nicotra, Gianluigi Forloni, Alfredo Cagnotto, Mario Salmona, Massimo Masserini, Giulio Sancini.   

Abstract

A promising strategy to enhance blood-brain barrier penetration by drugs is the functionalization of nanocarriers with uptake-facilitating ligands. We studied the cellular uptake, by cultured RBE4 brain capillary endothelial cells, of nanoliposomes (NLs) covalently coupled with monomer or tandem dimer of apolipoprotein E (ApoE)-derived peptides (residues 141-150), at various densities. NLs without functionalization did not show either relevant membrane accumulation or cellular uptake, as monitored by confocal microscopy and quantified by fluorescence-activated cell sorting. Functionalization with peptides mediated an efficient NLs uptake that increased with peptide density; NLs carrying monomeric peptide performed the best. Moreover, we studied the ability of ApoE-NLs to enhance the transport of a drug payload through a RBE4 cell monolayer. The permeability of a tritiated curcumin derivative was enhanced after its entrapment into ApoE-NLs, in particular those functionalized with the dimer (+83% with respect to free drug, P < 0.01). Thus, these NLs appear particularly suitable for implementing further strategies for drug brain targeting.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21658472     DOI: 10.1016/j.nano.2011.05.004

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  41 in total

1.  Mono and dually decorated nanoliposomes for brain targeting, in vitro and in vivo studies.

Authors:  E Markoutsa; K Papadia; A D Giannou; M Spella; A Cagnotto; M Salmona; G T Stathopoulos; S G Antimisiaris
Journal:  Pharm Res       Date:  2013-12-13       Impact factor: 4.200

Review 2.  Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance.

Authors:  David J Mc Carthy; Meenakshi Malhotra; Aoife M O'Mahony; John F Cryan; Caitriona M O'Driscoll
Journal:  Pharm Res       Date:  2014-12-02       Impact factor: 4.200

3.  The membrane axis of Alzheimer's nanomedicine.

Authors:  Yuhuan Li; Huayuan Tang; Nicholas Andrikopoulos; Ibrahim Javed; Luca Cecchetto; Aparna Nandakumar; Aleksandr Kakinen; Thomas P Davis; Feng Ding; Pu Chun Ke
Journal:  Adv Nanobiomed Res       Date:  2020-11-26

Review 4.  Nanoformulated Antiretrovirals for Penetration of the Central Nervous System: State of the Art.

Authors:  Luisa Fiandra; Amedeo Capetti; Luca Sorrentino; Fabio Corsi
Journal:  J Neuroimmune Pharmacol       Date:  2016-11-10       Impact factor: 4.147

5.  Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in Alzheimer's disease mouse models.

Authors:  Claudia Balducci; Simona Mancini; Stefania Minniti; Pietro La Vitola; Margherita Zotti; Giulio Sancini; Mario Mauri; Alfredo Cagnotto; Laura Colombo; Fabio Fiordaliso; Emanuele Grigoli; Mario Salmona; Anniina Snellman; Merja Haaparanta-Solin; Gianluigi Forloni; Massimo Masserini; Francesca Re
Journal:  J Neurosci       Date:  2014-10-15       Impact factor: 6.167

Review 6.  Blood brain barrier: An overview on strategies in drug delivery, realistic in vitro modeling and in vivo live tracking.

Authors:  Pawan Kumar Pandey; Ashok Kumar Sharma; Umesh Gupta
Journal:  Tissue Barriers       Date:  2015-12-15

Review 7.  Strategies for delivering therapeutics across the blood-brain barrier.

Authors:  Georg C Terstappen; Axel H Meyer; Robert D Bell; Wandong Zhang
Journal:  Nat Rev Drug Discov       Date:  2021-03-01       Impact factor: 84.694

Review 8.  Therapeutic Applications of Curcumin Nanoformulations.

Authors:  Murali M Yallapu; Prashanth K Bhusetty Nagesh; Meena Jaggi; Subhash C Chauhan
Journal:  AAPS J       Date:  2015-09-03       Impact factor: 4.009

9.  A novel hemoglobin-binding peptide reduces cell-free hemoglobin in murine hemolytic anemia.

Authors:  Madelyn S Hanson; Hao Xu; Timothy C Flewelen; Sandra L Holzhauer; Dawn Retherford; Deron W Jones; Anne C Frei; Kirkwood A Pritchard; Cheryl A Hillery; Neil Hogg; Nancy J Wandersee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-11-02       Impact factor: 4.733

10.  Curcumin nanomedicine: a road to cancer therapeutics.

Authors:  Murali M Yallapu; Meena Jaggi; Subhash C Chauhan
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.